SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-073354
Filing Date
2024-06-14
Accepted
2024-06-14 08:30:10
Documents
12
Period of Report
2024-06-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K igms-20240611.htm   iXBRL 8-K 90876
2 EX-3.1 igms-ex3_1.htm EX-3.1 8364
  Complete submission text file 0000950170-24-073354.txt   217678

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT igms-20240611.xsd EX-101.SCH 24818
15 EXTRACTED XBRL INSTANCE DOCUMENT igms-20240611_htm.xml XML 4709
Mailing Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043
Business Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043 650-965-7873
IGM Biosciences, Inc. (Filer) CIK: 0001496323 (see all company filings)

IRS No.: 770349194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39045 | Film No.: 241043221
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)